Depression affects millions of people in the United States every year. Though there are many effective treatments for depression, more than 30% of people fail to get relief from their symptoms from traditional treatments. At ReNew Infusions and East Valley Serenity Health in Gilbert, Arizona, Ginni Orava, MSN, FNP-C, Kamee Witts, RN, BSN, and the team offer Spravato® for patients struggling with treatment-resistant depression. To schedule a consultation with the mental health experts to see how Spravato can help you, call the office or book an appointment online today.
Spravato is a prescription nasal spray that is FDA-approved to treat adults with treatment-resistant depression and adults with major depressive disorder (MDD) with suicidal thoughts or actions.
The prescription nasal spray contains esketamine, which is made from the anesthetic ketamine. ReNew Infusions and East Valley Serenity Health also offers ketamine infusion therapy to treat mental health conditions and chronic pain.
Esketamine is more potent than ketamine, and you receive it in lower doses, which may cause fewer side effects.
Only Risk Evaluation and Mitigation (REMS) certified treatment centers like ReNew Infusions and East Valley Serenity Health administer Spravato.
As a REMS treatment center, the team provides your Spravato treatments at the office under close supervision. This helps reduce the risk of misuse and abuse of the medication.
Most insurance companies cover the cost of Spravato.
The team at ReNew Infusions and East Valley Serenity Health determines if you’re a candidate for Spravato after a comprehensive evaluation. Make an appointment today to see if Spravato can help you.
The mental health clinic uses Spravato for patients with treatment-resistant depression, as well as patients with MDD symptoms that include suicidal thoughts or actions. The team only uses this nasal medication in conjunction with oral antidepressants.
You may not be a candidate for Spravato if you have aneurysmal vascular disease, a history of intracerebral hemorrhage, or sensitivity to ketamine or esketamine. It’s also not recommended for pregnant women or women who may become pregnant and people age 65 and older.
ReNew Infusions and East Valley Serenity Health administers Spravato at the office. Typically, the treatment schedule for Spravato is as follows:
Because of the potential side effects, such as sedation or dissociation, you must plan to stay at the office for up to two hours following the administration of your medication. You must also arrange to have someone drive you home and take it easy the rest of the day.
The team at ReNew Infusions and East Valley Serenity Health gives you specific instructions on what you need to do prior to your Spravato treatments. In general, the team recommends you stop eating at least two hours before your scheduled appointment and stop drinking 30 minutes before.
To see if you’re a candidate for Spravato, call ReNew Infusions and East Valley Serenity Health, or book an appointment online today.